
More targeted and less aggressive radiotherapy for low-risk breast cancer could spare thousands of women from the harsh side-effects of the treatment, a trial has found.
The technique, which has since been adopted by the NHS, has “transformed” the way the disease is treated in its early stages, researchers said.